Safety and efficacy of the HER2-derived GP2 peptide vaccine in combination with trastuzumab for breast cancer patients in the adjuvant setting.

Authors

null

Ritesh Patil

Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY

Ritesh Patil , Guy T. Clifton , Jennifer Keating Litton , Nathan M. Shumway , Timothy J Vreeland , John S. Berry IV, Alfred F Trappey III, Sathibalan Ponniah , George Earl Peoples , Elizabeth Ann Mittendorf

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics - Immunotherapy

Track

Developmental Therapeutics

Sub Track

Vaccines

Citation

J Clin Oncol 31, 2013 (suppl; abstr 3096)

DOI

10.1200/jco.2013.31.15_suppl.3096

Abstract #

3096

Poster Bd #

20G

Abstract Disclosures